[CADL] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 52.12%
YoY- -26.21%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 1,776 0 0 0 -
PBT -10,646 -22,237 -8,221 -11,095 -8,435 -9,614 -8,795 13.54%
Tax 0 0 208 386 -90 644 -940 -
NP -10,646 -22,237 -8,221 -11,095 -8,435 -9,614 -7,855 22.40%
Tax Rate - - - - - - - -
Total Cost 10,646 22,237 8,221 12,871 8,435 9,614 7,855 22.40%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -624.72 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.33 -0.74 -0.28 -0.38 -0.29 -0.33 -0.27 14.27%
EPS Diluted -0.33 -0.74 -0.28 -0.38 -0.29 -0.33 -0.27 14.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.